FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
About | Sample | Privacy
Related Topics >> FDA | Merck | GlaxoSmithKline | Regulators | virus

SPOTLIGHT: Rotarix gets FDA committee nod

An FDA advisory panel agreed Wednesday that GlaxoSmithKline's Rotarix vaccine was safe and effective, recommending the anti-rotavirus shot for agency approval. Rotarix is designed to help protect infants from gastrointestinal illness caused by that virus. The FDA is set to say yea or nay by April 3. If approved for sale, Rotarix will compete with Merck's RotaTeq, which has been on the market since 2006. Report

More stories about FDA   Merck   GlaxoSmithKline   Regulators   virus  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 94 + 1?
To combat spam, please solve the math question above.